Skip to main content
IDF logo

Patient-informed continuing education course on PI wins award

March 02, 2023

In August 2021, IDF, the American Academy of Allergy, Asthma, and Immunology (AAAAI), and the AXDEV Group launched a three-module online course for healthcare providers called “Providing Enhanced Medical Support for Patients with Primary Immunodeficiency Disorders (PIDD): A Patient-Guided Intervention to Ensure Patient Engagement During a Global Pandemic and Beyond.” The course was recently awarded the Alliance for Continuing Education in the Health Professions’ 2023 William Campbell Felch Award for Research in Continuing Education. The Felch Award is given to outstanding research projects in the continuing education space. 

Jorey Berry, Steve Folstein, and Christopher Scalchunes pose with the Felch Award.
From left to right: Jorey Berry (IDF), Steve
Folstein (AAAAI), and Christopher Scalchunes
pose with the Foley Award in front of a poster
describing the CE course.

Project leaders rooted the course in research. To design it, they surveyed 315 patients with primary immunodeficiency (PI) to identify issues related to overall provider knowledge of PI symptoms and diagnosis, provider-patient communication, and telehealth practices. The insights from this survey informed both the learning objectives and the content of the course modules. The modules include:

  1. Signs and Symptoms of PIDD
  2. Beyond the Doctor’s Office: Telehealth for PIDD Patient Care
  3. Diagnosis: A Practical Patient Scenario (with one version for allergists/immunologists and another for primary care providers)

By having providers take a pre-assessment and then post-assessments after each module, project leaders were able to measure how effective the modules were in addressing the gaps originally identified in the patient survey. The module post-assessments showed that participants’ knowledge significantly increased in recognizing specific PI symptoms, selecting patients for telehealth visits, addressing mental health and co-occurring conditions during telehealth visits, and selecting an appropriate treatment plan for a patient with PI. 

In addition, participants completed another post-assessment at least 30 days after completing the modules to measure their enduring knowledge and practice changes. The majority of participants reported that they continue to ask patients about their full range of symptoms, address other factors impacting health during telehealth visits, and create an action plan with patients at the end of each visit.

Poster describing development and assessment of AAAAI/IDF course.

The award-winning course was supported by Pfizer and is available online for free until June 30, 2023. Health professionals can earn up to two continuing medical education (CME) or continuing education (CE) credits for completing all of the course components and modules.